Intranasal Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the PED

Clinical trial NCT04150757 · TERMINATED

Trial details

NCT number: NCT04150757
Sponsor: Abigail Nixon
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Sickle Cell Disease Vaso-Occlusive Pain Episode in Sickle Cell Disease Vaso-occlusive Crisis Ketamine Intranasal Ketamine Analgesia

Start date: 2019-12-19
Primary completion: 2020-10-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.